GSK Plc (GSK)
49.22
-1.18
(-2.35%)
USD |
NYSE |
Nov 17, 16:00
49.20
-0.02
(-0.05%)
After-Hours: 20:00
GSK Price : 49.22 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 51.23 | 51.43 | 50.38 | 50.41 | 2.946M |
| Nov 13, 2026 | 50.25 | 50.80 | 50.13 | 50.45 | 2.781M |
| Nov 12, 2026 | 50.97 | 51.07 | 50.45 | 50.64 | 2.547M |
| Nov 11, 2026 | 50.18 | 50.64 | 49.79 | 50.60 | 2.701M |
| Nov 10, 2026 | 51.50 | 51.89 | 51.02 | 51.23 | 2.624M |
| Nov 09, 2026 | 51.19 | 51.64 | 50.59 | 51.54 | 3.573M |
| Nov 06, 2026 | 49.07 | 50.74 | 48.94 | 50.33 | 3.185M |
| Nov 05, 2026 | 50.58 | 51.43 | 50.26 | 50.41 | 3.060M |
| Nov 04, 2026 | 50.82 | 51.28 | 50.08 | 51.15 | 5.281M |
| Nov 03, 2026 | 49.41 | 49.56 | 48.62 | 48.70 | 3.112M |
| Nov 02, 2026 | 49.17 | 49.50 | 48.90 | 49.13 | 2.655M |
| Oct 30, 2026 | 49.84 | 50.28 | 49.25 | 49.51 | 4.767M |
| Oct 29, 2026 | 48.19 | 49.11 | 48.02 | 48.68 | 5.610M |
| Oct 28, 2026 | 47.65 | 49.32 | 47.36 | 48.74 | 8.116M |
| Oct 27, 2026 | 50.80 | 51.25 | 50.64 | 50.94 | 4.773M |
| Oct 26, 2026 | 50.86 | 51.24 | 50.85 | 51.10 | 3.609M |
| Oct 23, 2026 | 50.83 | 50.92 | 50.29 | 50.75 | 3.179M |
| Oct 22, 2026 | 50.29 | 51.44 | 49.96 | 51.21 | 4.283M |
| Oct 21, 2026 | 50.19 | 50.44 | 49.91 | 50.02 | 3.614M |
| Oct 20, 2026 | 49.98 | 51.12 | 49.77 | 50.63 | 5.598M |
| Oct 19, 2026 | 49.44 | 49.81 | 49.26 | 49.46 | 5.373M |
| Oct 16, 2026 | 49.62 | 49.96 | 49.44 | 49.51 | 6.924M |
| Oct 15, 2026 | 49.18 | 49.84 | 48.98 | 49.02 | 6.142M |
| Oct 14, 2026 | 46.63 | 47.98 | 46.55 | 47.87 | 7.088M |
| Oct 13, 2026 | 47.09 | 47.15 | 46.10 | 46.27 | 5.756M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 182.24 |
| Johnson & Johnson | 279.00 |
| Eli Lilly & Co. | 1410.01 |
| Merck & Co., Inc. | 143.29 |
| Novo Nordisk A/S | 40.70 |
Price Related Metrics
| PE Ratio | 17.16 |
| PS Ratio | 2.230 |
| Price to Book Value | 3.961 |
| Price to Free Cash Flow | 12.78 |
| Earnings Yield | 5.83% |
| Market Cap | 98.67B |
| Operating PE Ratio | 9.013 |
| Normalized PE Ratio | 10.83 |